arrow
D

David Herrmann

Garvan Institute of Medical Research and Kinghorn Cancer Centre
H指数:32
被引数:4,186

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

一种一流的泛赖氨酰氧化酶抑制剂可削弱胰腺癌的基质重塑并增强吉西他滨反应和生存率

2023-08-2823
OAAI
Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse
2023-04-281
OAAI
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis

乳腺肿瘤微环境的时间分布显示胶原蛋白XII是转移的驱动因素

2022-08-0697
OAAI
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status

根据Merlin状态,活体成像技术指导FAK介导的胰腺癌精准医学启动

2021-10-0130
OAAI
Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging
2021-09-0117
OAAI
Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis
2021-06-24107
OAAI
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan

由胰腺癌细胞p53-status驱动的CAF层次结构通过perlecan创造了一个促转移和化学抗性的环境

2019-08-12184
OAAI
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer

靶向基质重塑和癌症干细胞可塑性克服了三阴性乳腺癌的化学抗性

2018-07-24326
OAAI
Removing physiological motion from intravital and clinical functional imaging data
2018-07-0938
OAAI